These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27693368)

  • 41. Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach.
    Rohof WO; Bennink RJ; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1101-1107.e1. PubMed ID: 24726906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
    Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2019 May; 17(5):345-351. PubMed ID: 31092056
    [No Abstract]   [Full Text] [Related]  

  • 44. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 45. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitor use in infants: FDA reviewer experience.
    Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
    Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
    Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase.
    Mullin JM; Valenzano MC; Whitby M; Lurie D; Schmidt JD; Jain V; Tully O; Kearney K; Lazowick D; Mercogliano G; Thornton JJ
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1317-25. PubMed ID: 18684245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?
    Bruley des Varannes S; Coron E; Galmiche JP
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):905-21. PubMed ID: 21126703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency.
    Giani J; Chambers CR; Sawyer MB
    J Oncol Pharm Pract; 2022 Mar; 28(2):457-461. PubMed ID: 34565254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.